Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
509
datasets available to search
ShareScore release 0.9.0
Dataset results
509 results for “Hepatitis C Virus”
A First in Human Study of AL-611 in Healthy Volunteers and Patients With Hepatitis C Virus Infection
ClinicalTrials.gov study NCT03253471. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination in Treatment-Naïve Hepatitis C Virus Participants (MK-5172-067)
ClinicalTrials.gov study NCT02251990. IPD Sharing: YES. Countries: 0. Publications: 5.
Ribavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) Recipients
ClinicalTrials.gov study NCT00993122. IPD Sharing: Not stated. Countries: 1. Publications: 10.
An Observational Study of Hepatitis C Virus in Pregnancy
ClinicalTrials.gov study NCT01959321. IPD Sharing: YES. Countries: 1. Publications: 2.
Assessment of the Antiviral Effect of Atorvastatin on Hepatitis C Virus
ClinicalTrials.gov study NCT00403533. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects With Chronic Hepatitis C Virus (HCV) and Inherited Bleeding Disorders
ClinicalTrials.gov study NCT02120300. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use
ClinicalTrials.gov study NCT02336139. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study to Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond t
ClinicalTrials.gov study NCT01609933. IPD Sharing: UNDECIDED. Countries: 0. Publications: 1.
Safety, Tolerability and PK Study of Single Doses of ABT-450 With and Without Ritonavir to Treat Hepatitis C Virus (HCV) Genotype 1
ClinicalTrials.gov study NCT00850044. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) in Japanese Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) Infection
ClinicalTrials.gov study NCT02023099. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection.
ClinicalTrials.gov study NCT00502086. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Use-Results Surveillance Study of Harvoni® in Japanese Patients With Chronic Genotype 1 Hepatitis C Virus Infection
ClinicalTrials.gov study NCT02591277. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Combination Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Sofosbuvir + Pegylated Interferon + Ribavirin in Hepatitis C Virus Genotype 1, 4 or 6 Infection (MK-5172-077)
ClinicalTrials.gov study NCT02358044. IPD Sharing: YES. Countries: 0. Publications: 5.
FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral Therapy
ClinicalTrials.gov study NCT00606528. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Ombitasvir/ABT-450 (Paritaprevir)/Ritonavir With Dasabuvir and Ribavirin (RBV) in Treatment Naive and Treatment Experienced Genotype 1a Hepatitis C Virus Infected Adults
ClinicalTrials.gov study NCT02476617. IPD Sharing: Not stated. Countries: 0. Publications: 2.
HCV (Hepatitis C Virus) Viral and Host Genotyping (IL28B, Interleukin 28B) in China
ClinicalTrials.gov study NCT01293279. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy
ClinicalTrials.gov study NCT01434212. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Therapy for Hepatitis C Virus (HCV) in Primary Treatment Failure in Pakistan
ClinicalTrials.gov study NCT05248919. IPD Sharing: NO. Countries: 1. Publications: 9.
Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065)
ClinicalTrials.gov study NCT02252016. IPD Sharing: YES. Countries: 0. Publications: 2.
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Renally Impaired Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection
ClinicalTrials.gov study NCT02651194. IPD Sharing: Not stated. Countries: 0. Publications: 6.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.